(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INVICTUS NUTRACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INVICTUS NUTRACEUTICALS

ST13

US500000079307472

Class

5

Filing

79307472

Registration

6908891

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

04/12/2023

Trademark type

Combined

Nice classes

5

Filing date

01/11/2021

Registration date

11/29/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/29/2022

Last transaction

11/29/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

AU

Examiner

TRUSILO, KELLY

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "INVICTUS" surrounded by a partial circle of laurel leaf branches appearing from the top of the letter "V" and "T" and joined underneath the word, appearing above the word "NUTRACEUTICALS".

Holders and representatives

Holders

Invictus Biotechnology Pty Ltd

Representatives

Lindsay J. Hulley Rutan & Tucker, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; dietary supplement drinks for energy; food supplements in the nature of dietary supplements; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal purposes; plant extracts in the nature of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations being food supplements; medicated supplements for foodstuffs for humans; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; dietary supplemental drinks in the nature of vitamin drinks; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for muscle injuries and disorderssports related injuriesimproving exercise endurancecapacity and performanceincreasing antioxidant levelsmaintaining cholesterol and improving cardiovascular healthfor human purposes; medicines for human use for muscle injuries and disorders and sports related injuries and for improving exercise endurancecapacity and performance; medicines for preventing muscle injuries and disorderssports related injuries ailmentscardiovascular ailments; medicines for treatment of heart related diseases and disorders; medicinal preparations for the mouth to be applied in the form of tablets; tablets for medicinesdrug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for the prevention of muscle injuries and disorderssports related injuriesimproving exercise endurancecapacity and performanceincreasing antioxidant levelsmaintaining cholesterol at normal levels in healthy individuals and improving cardiovascular health; pharmaceutical tablets for muscle injuries and disorderssports related injuriesimproving exercise endurancecapacity and performanceimproving exercise endurancecapacity and performanceincreasing antioxidant levelsmaintaining cholesterol at normal levels in healthy individuals and improving cardiovascular health; specialized tablets for the delivery of pharmaceuticals sold without the pharmaceutical ingredient

Publications

History of USPTO decisions and trademark events.

35 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/12/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/21/2023

FIMP

FINAL DISPOSITION PROCESSED

03/20/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/28/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/29/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/29/2022

GPNX

NOTIFICATION PROCESSED BY IB

10/02/2022

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

09/20/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/13/2022

PUBO

PUBLISHED FOR OPPOSITION

09/13/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/07/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/07/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/31/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

08/31/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/24/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/20/2022

ALIE

ASSIGNED TO LIE

07/19/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/30/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/01/2022

GNSL

LETTER OF SUSPENSION E-MAILED

03/01/2022

CNSL

SUSPENSION LETTER WRITTEN

03/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/15/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/14/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/14/2022

RFNT

REFUSAL PROCESSED BY IB

09/05/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/19/2021

RFRR

REFUSAL PROCESSED BY MPU

08/19/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/06/2021

CNRT

NON-FINAL ACTION WRITTEN

08/05/2021

DOCK

ASSIGNED TO EXAMINER

07/21/2021

MAFR

APPLICATION FILING RECEIPT MAILED

04/02/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/29/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/25/2021

Continuous trademark protection

Get notified about every new filing that threatens INVICTUS NUTRACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.